SRNE

SORRENTO THERAPEUTICS INC by Sorrento Therapeutics, Inc. (SRNE)

About SORRENTO THERAPEUTICS INC by Sorrento Therapeutics, Inc. (SRNE)

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. The Sorrento Therapeutics segment consists of developing a portfolio of next generation treatments for three major therapeutic areas: cancer, infectious disease, and pain. The Scilex segment is largely organized around the company's non-opioid pain management operations. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.10
52 Week Low
$0.00
Market cap
2.2M
Dividend yield
0.00%
Volume
480,544
Avg. volume
445,441
P/E ratio
--

SORRENTO THERAPEUTICS INC by Sorrento Therapeutics, Inc. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.10
52 Week Low
$0.00
Market cap
2.2M
Dividend yield
0.00%
Volume
480,544
Avg. volume
445,441
P/E ratio
--